# Validation of a Circulating Tumor DNA Blood Test in Muscle-Invasive Bladder and Upper Tract Urothelial Cancer

> **NCT07756437** · — · RECRUITING · sponsor: **AZ Sint-Lucas Gent** · enrollment: 70 (estimated)

## Conditions studied

- Muscle-Invasive Bladder Cancer (MIBC)
- Upper Tract Urothelial Carcinoma
- Urothelial Carcinoma (UC)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07756437
- **Lead sponsor:** AZ Sint-Lucas Gent
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-07
- **Primary completion:** 2027-09-30
- **Final completion:** 2029-06-01
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2026-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07756437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07756437, "Validation of a Circulating Tumor DNA Blood Test in Muscle-Invasive Bladder and Upper Tract Urothelial Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07756437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*